Khalil Barrage

Khalil Barrage is a board member at Sensorion and Orthobond Corporation. He has worked in these positions since June 2019 and June 2017, respectively.

Khalil Barrage has worked at The Invus Group from September 2003 to present as Managing Director. He is responsible for the public equities division and started the activity for the Invus Group in 2003. The Invus Group is an investment firm managing an evergreen fund structure of over $8 billion with offices in New York, Paris, and Hong Kong. On the private side, The Invus Group focuses on transformational of high-growth opportunities. On the public equities side, The Invus Group runs a long-only concentrated portfolio of stocks that are trading below their intrinsic business value.

Khalil Barrage worked as a board member at Celtaxsys from April 2013 to May 2015. During his time there, he was focused on developing new treatments for inflammatory diseases by modulating innate immunity. He helped build a sustainable pipeline of first-in-class drugs with novel mechanisms of action.